Antibody Shows Promise Against Obesity-related Liver Disease and Atherosclerosis in Mice
Latest research in the FASEB Journal reveals an antibody called bFKB1 improves liver disease and atherosclerosis in a mouse model of metabolic dysfunction-associated steatohepatitis (MASH), which is associated with obesity.
28-Oct-2024 3:50 PM EDT
Add to Favorites